Researchers discuss disrupting NKG2A:HLA-E interactions for enhanced anti-cancer immunity
A new editorial titled "Strategies to disrupt NKG2A:HLA-E interactions for improved anti-cancer immunity" has been published in Oncotarget.
Aug 21, 2024
0
47
Immune System Diseases: News and Research on Leukemia, Lymphocytic, Chronic, B-Cell
MeSH tree: C20.683.515.528.080.125
Outcomes may improve with ibrutinib in chronic lymphocytic leukemia
First-line ibrutinib is associated with better outcomes than chemoimmunotherapy among patients with chronic lymphocytic leukemia (CLL), according to a study published online May 13 in Clinical Lymphoma, Myeloma & Leukemia.
Jun 21, 2024
0
41
Reduced infections seen in CLL and NHL patients undergoing immunoglobulin testing and replacement therapy
Patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHLs) who received frequent tests for immunoglobulin G (IgG) were less likely to experience severe infections compared with those who didn't, according ...
Jun 21, 2024
0
34
Exercise bouts could improve efficacy of cancer drug
Bouts of moderate-to-vigorous intensity exercise could improve the efficacy of antibody therapies used to treat chronic lymphocytic leukemia, new research has shown.
May 21, 2024
0
48
Study shows 'feasibility' of ending specialist follow-up in patients with low-risk chronic lymphocytic leukemia
A study published in Blood Advances showed that among patients in Denmark who had slow-growing chronic lymphocytic leukemia (CLL) with no symptoms and a low risk for ever needing treatment, those who stopped seeing their ...
Apr 4, 2024
0
32
FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T-cell therapy for adult patients with relapsed ...
Mar 19, 2024
0
56
Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors
New research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations has identified a next-generation BTK degrader that could help overcome treatment ...
Feb 1, 2024
0
70
Here's why some high-risk patients aren't getting drugs to combat COVID
As the toll from the COVID-19 pandemic continued to mount, antiviral medications such as Paxlovid were hailed by health officials as an important way to reduce the risk of severe illness or death.
Jan 25, 2024
0
50
New personalized therapy improves survival for patients with CLL leukemia, phase 3 trial finds
Personalized treatment for the most common form of adult leukemia helps patients survive for longer and stay in remission, a phase 3 trial has found.
Dec 11, 2023
0
47
Psychological distress reported for indolent non-Hodgkin lymphomas
Patients with indolent non-Hodgkin lymphomas (iNHL) report considerable psychological distress, according to a study published online Nov. 3 in The Oncologist.
Nov 21, 2023
0
105
